Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs
Rachel Sacks‐Davis(Burnet Institute), Margaret Hellard(The Alfred Hospital), Jason Grebely(UNSW Sydney), David A. Rolls(Australian Psychological Society), Lilly Tracy(Victorian Infectious Diseases Reference Laboratory), Galina Daraganova(University of Melbourne), Alyssa E. Barry(Burnet Institute), Philippa Pattison(The University of Sydney), Garry Robins(The University of Melbourne), Rebecca Jenkinson(Burnet Institute), Campbell Aitken(Burnet Institute), Scott Bowden(Victorian Infectious Diseases Reference Laboratory), Peter Higgs(Curtin University)
Cited by 96
Related Papers
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
|Hepatology|2013|393
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
|Clinical Infectious Diseases|2009|234
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2018|228